What are the types of eyelid cancers and their recommended treatments?

Eyelid Cancers: Types and Treatment

The five most common malignant eyelid tumors are basal cell carcinoma (most frequent at ~50-80%), squamous cell carcinoma, sebaceous gland carcinoma, melanoma, and Merkel cell carcinoma, with surgical excision achieving tumor-free margins as the gold standard treatment for all types 1, 2, 3.

Types of Eyelid Malignancies

Basal Cell Carcinoma (BCC)

• Most common eyelid malignancy (52-82% of cases)
• Predominantly affects the lower eyelid (81.8% of cases)
• Nodular subtype is most frequent
• Rarely metastasizes except in exceptional cases 4, 5, 6

Squamous Cell Carcinoma (SCC)

• Second most common eyelid malignancy
• Higher metastatic potential than BCC
• Requires lymph node assessment when regional nodes are palpable or abnormal on imaging 7

Sebaceous Gland Carcinoma

• Third most common (approximately 32% in some series)
• Critical diagnostic consideration: suspect in elderly patients with unresponsive, chronic, unilateral blepharitis or conjunctivitis, or recurrent chalazia in the same location
• May have multicentric origin with pagetoid spread causing severe conjunctival inflammation
• Difficult to diagnose and often mimics benign conditions 1, 4, 5

Melanoma

• Fourth most common
• Age ≥60 significantly increases risk (17-fold increased incidence rate ratio)
• Requires aggressive management due to metastatic potential 4, 8

Merkel Cell Carcinoma (MCC)

• Least common of the five major types
• High-grade neuroendocrine tumor with significant metastatic potential
• Requires sentinel lymph node biopsy for staging 9, 8

Clinical Red Flags for Malignancy

Suspect malignancy when you observe:

• Nodular mass
• Ulceration
• Extensive scarring
• Lash loss (madarosis)
• Localized crusting and scaling of the dermis
• Yellow conjunctival nodules surrounded by intense inflammation
• Atypical eyelid-margin inflammation unresponsive to medical therapy
• Unilateral, chronic blepharitis or conjunctivitis (especially sebaceous carcinoma) 4

Treatment Algorithm

Primary Treatment: Surgical Excision

Complete surgical excision with tumor-free margins is the definitive treatment for all eyelid malignancies 1, 10, 7, 2.

Surgical Technique Selection:

1. Mohs Micrographic Surgery or Complete Circumferential Peripheral and Deep Margin Assessment (CCPDMA)

   • Preferred technique for optimal local control and eyelid tissue preservation
   • Superior margin control compared to standard excision
   • Allows real-time margin assessment 10, 7, 2, 11

2. Standard Excision with Postoperative Margin Assessment (POMA)

   • Alternative when Mohs surgery unavailable
   • Requires adequate margins based on tumor type 7

3. Intraoperative Frozen Section Control

   • Mandatory for all cases to ensure negative margins
   • Positive intraoperative frozen margins are a significant risk factor for local recurrence (7-fold increased odds) 5, 6

Margin Requirements:

• Margins tailored to tumor type and histology
• Excision to investing fascia layer with complete peripheral margin examination 9

Reconstruction After Excision

Defect size determines reconstruction approach 6:

• <40% defect: Direct lid closure often sufficient
• ≥40% defect: Requires flap or graft techniques
  • Anterior lamella: Tenzel semicircular flap (most commonly used)
  • Posterior lamella: Hughes tarsoconjunctival flap (most commonly used)

Lymph Node Management

For Squamous Cell Carcinoma, Melanoma, and Merkel Cell Carcinoma:

1. Palpable or imaging-abnormal lymph nodes: Perform fine-needle aspiration (FNA)

   • If FNA positive → imaging to determine extent → completion lymph node dissection
   • If FNA negative in head/neck → consider repeat FNA or open biopsy
   • If FNA negative in trunk/extremity → proceed to open biopsy 7

2. Sentinel Lymph Node Biopsy (SLNB)

   • Recommended for Merkel cell carcinoma in otherwise healthy patients
   • Perform before definitive local excision for accuracy
   • Use CK-20 immunostaining and pancytokeratins for pathologic assessment
   • Positive sentinel node → completion lymph node dissection and/or radiation therapy 9
   • Lymph node involvement is the strongest predictor of recurrence (21-fold increased odds) 5

Adjuvant Radiation Therapy

Indications for postoperative radiation:

• High-risk features present
• Positive or close margins that cannot be re-excised
• Regional lymph node involvement
• Evidence shows: reduces local and regional recurrence rates 9, 7

Systemic Therapy for Advanced/Metastatic Disease

When surgical excision is not feasible or for metastatic disease 2, 11, 12:

1. Melanoma and Merkel Cell Carcinoma:

   • PD-1/PD-L1 checkpoint inhibitors
   • Demonstrates enhanced progression-free survival and durable responses

2. Advanced Basal Cell Carcinoma:

   • Hedgehog pathway inhibitors (smoothened inhibitors)

3. Advanced Squamous Cell Carcinoma:

   • Checkpoint inhibitors

Non-Surgical Options (Limited Role)

Only for low-risk, small BCCs when surgery contraindicated:

• Topical 5-fluorouracil or imiquimod
• Photodynamic therapy
• Cryotherapy
• Note: These are NOT standard of care for eyelid malignancies 10, 7

Follow-Up and Surveillance

• Long-term surveillance mandatory due to recurrence risk
• Frequency based on tumor type, stage, and risk factors
• Higher-risk tumors (sebaceous carcinoma, melanoma, MCC) require more intensive monitoring
• Monitor for new primary lesions 2, 13

Critical Pitfalls to Avoid

1. Do not perform superficial biopsies - may miss deeper tumor components; excisional biopsy preferred when feasible 7
2. Do not perform wide local excision before SLNB - interferes with accuracy of sentinel node mapping 9
3. Do not use curettage and electrodesiccation for eyelid tumors - inadequate for this anatomic location
4. Do not dismiss chronic unilateral blepharitis - always biopsy to rule out sebaceous carcinoma 4
5. Do not accept positive margins - re-excision or radiation therapy required 5